Atlas Trials

UB-312 in Patients With Synucleinopathies

Clinical trial NCT05634876 · COMPLETED

Trial details

NCT number
NCT05634876
Sponsor
NYU Langone Health
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple System AtrophyParkinson Disease
Start date
2023-05-31
Primary completion
2025-02-11
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.